EE03437B1 - Benseenamiidid neurodegeneratiivsete haiguste ravimiseks - Google Patents

Benseenamiidid neurodegeneratiivsete haiguste ravimiseks

Info

Publication number
EE03437B1
EE03437B1 EE9700235A EE9700235A EE03437B1 EE 03437 B1 EE03437 B1 EE 03437B1 EE 9700235 A EE9700235 A EE 9700235A EE 9700235 A EE9700235 A EE 9700235A EE 03437 B1 EE03437 B1 EE 03437B1
Authority
EE
Estonia
Prior art keywords
benzenamides
treatment
neurodegenerative diseases
neurodegenerative
diseases
Prior art date
Application number
EE9700235A
Other languages
English (en)
Estonian (et)
Other versions
EE9700235A (et
Inventor
David Flitter William
A. Garland William
L. Wilcox Allan
E. Paylor Richard
Original Assignee
Centaur Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/415,694 external-priority patent/US5658953A/en
Priority claimed from US08/415,847 external-priority patent/US5643965A/en
Priority claimed from US08/415,248 external-priority patent/US5659082A/en
Application filed by Centaur Pharmaceuticals, Inc. filed Critical Centaur Pharmaceuticals, Inc.
Publication of EE9700235A publication Critical patent/EE9700235A/xx
Publication of EE03437B1 publication Critical patent/EE03437B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/38Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/64Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/65Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/30Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/42Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EE9700235A 1995-04-03 1996-04-03 Benseenamiidid neurodegeneratiivsete haiguste ravimiseks EE03437B1 (et)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US41567795A 1995-04-03 1995-04-03
US08/415,694 US5658953A (en) 1995-04-03 1995-04-03 Pharmaceutical compositions of acetamidobenzamide compounds for neurodegenerative disorders
US08/415,847 US5643965A (en) 1995-04-03 1995-04-03 Aminobenzamide compounds for the treatment of neurodegenerative disorders
US08/415,248 US5659082A (en) 1995-04-03 1995-04-03 Nitro- and aminobenzamide compounds for neurodegenerative disorders
PCT/US1996/004538 WO1996031462A1 (en) 1995-04-03 1996-04-03 Benzamides for neurodegenerative disorder treatment

Publications (2)

Publication Number Publication Date
EE9700235A EE9700235A (et) 1998-04-15
EE03437B1 true EE03437B1 (et) 2001-06-15

Family

ID=27503636

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700235A EE03437B1 (et) 1995-04-03 1996-04-03 Benseenamiidid neurodegeneratiivsete haiguste ravimiseks

Country Status (39)

Country Link
EP (1) EP0819113B1 (xx)
JP (1) JP3479658B2 (xx)
KR (1) KR100429120B1 (xx)
CN (1) CN1073552C (xx)
AR (1) AR002978A1 (xx)
AT (1) ATE202552T1 (xx)
AU (1) AU721045B2 (xx)
BG (1) BG63384B1 (xx)
CA (1) CA2215166A1 (xx)
CO (1) CO4700431A1 (xx)
CZ (1) CZ295852B6 (xx)
DE (1) DE69613567T2 (xx)
DK (1) DK0819113T3 (xx)
DZ (1) DZ2012A1 (xx)
EA (1) EA002031B1 (xx)
EE (1) EE03437B1 (xx)
ES (1) ES2160240T3 (xx)
GR (1) GR3036466T3 (xx)
HK (1) HK1016964A1 (xx)
HR (1) HRP960156B1 (xx)
HU (1) HUP9801759A3 (xx)
IL (1) IL117629A (xx)
IS (1) IS1919B (xx)
MA (1) MA23837A1 (xx)
MX (1) MX9707596A (xx)
MY (1) MY121206A (xx)
NO (1) NO318441B1 (xx)
NZ (1) NZ306204A (xx)
PL (1) PL184121B1 (xx)
PT (1) PT819113E (xx)
RO (1) RO116190B1 (xx)
SA (1) SA96160739B1 (xx)
SI (1) SI0819113T1 (xx)
SK (1) SK282900B6 (xx)
TN (1) TNSN96051A1 (xx)
TR (1) TR199701114T1 (xx)
TW (1) TW381073B (xx)
WO (1) WO1996031462A1 (xx)
YU (1) YU21096A (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW412421B (en) * 1996-04-17 2000-11-21 Centaur Pharmaceuticals Inc Benzamide treatment of dementia associated with AIDS virus (HIV-1) infection
EP1034783B1 (en) * 1997-10-27 2004-12-15 Sumitomo Pharmaceuticals Company, Limited Amide derivatives for the treatment of retinal neurodegenerative disorders
US6271265B1 (en) 1998-05-19 2001-08-07 Centaur Pharmaceuticals, Inc. Amide therapeutics for the treatment of inflammatory bowel disease
EP1079820A1 (en) * 1998-05-19 2001-03-07 Centaur Pharmaceuticals, Inc. Benzamide therapeutics for the treatment of inflammatory bowel disease
WO2000064430A1 (fr) * 1999-04-23 2000-11-02 Sumitomo Pharmaceuticals Co., Ltd. Inhibiteurs de l'apoptose
CN101817761B (zh) * 2010-01-29 2014-06-25 浙江大学 苯甲酸酯类衍生物及制备方法和应用
US9206125B2 (en) 2010-02-10 2015-12-08 Public University Corporation Yokohama City University Use of compound binding to mSin3B that specifically binds to neuron restrictive silencer factor (NRSF)
WO2014155184A1 (en) * 2013-03-28 2014-10-02 Rhenovia Pharma Treatment for parkinson's disease
CN115594603A (zh) * 2022-10-09 2023-01-13 湖北师范大学(Cn) 微通道反应器制备n-叔丁基-4-氨基苯甲酰胺的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1069882B (it) * 1975-12-22 1985-03-25 Mallinckrodt Inc 3 5 bis acilammino benzammidi particolarmente utili come agenti di contrasto per raffi x e procedimento per la loro preparazione
JPS5721320A (en) * 1980-07-11 1982-02-04 Chugai Pharmaceut Co Ltd Blood sugar level depressing agent
JPS5867657A (ja) * 1981-10-15 1983-04-22 Chugai Pharmaceut Co Ltd ペンズアミド誘導体
US5472983A (en) * 1994-04-14 1995-12-05 Centaur Pharmaceuticals, Inc. Benzamide-containing pharmaceutical compositions

Also Published As

Publication number Publication date
CO4700431A1 (es) 1998-12-29
EE9700235A (et) 1998-04-15
DE69613567D1 (de) 2001-08-02
AU721045B2 (en) 2000-06-22
JP3479658B2 (ja) 2003-12-15
PL184121B1 (pl) 2002-09-30
TW381073B (en) 2000-02-01
YU21096A (sh) 1999-03-04
CN1073552C (zh) 2001-10-24
IS1919B (is) 2004-03-15
EP0819113B1 (en) 2001-06-27
ATE202552T1 (de) 2001-07-15
GR3036466T3 (en) 2001-11-30
IL117629A (en) 2000-08-13
EA002031B1 (ru) 2001-12-24
DZ2012A1 (fr) 2002-07-21
HUP9801759A2 (hu) 1998-12-28
KR100429120B1 (ko) 2004-08-18
HRP960156B1 (en) 2002-04-30
AU5440496A (en) 1996-10-23
ES2160240T3 (es) 2001-11-01
MX9707596A (es) 1998-06-30
BG63384B1 (bg) 2001-12-29
WO1996031462A1 (en) 1996-10-10
JPH11501319A (ja) 1999-02-02
HUP9801759A3 (en) 2001-06-28
PL322625A1 (en) 1998-02-02
TR199701114T1 (xx) 1998-02-21
NO318441B1 (no) 2005-03-21
CN1182416A (zh) 1998-05-20
SK132597A3 (en) 1998-09-09
EA199700287A1 (ru) 1998-04-30
SK282900B6 (sk) 2003-01-09
MA23837A1 (fr) 1996-12-31
BG101929A (en) 1998-04-30
KR19980703562A (ko) 1998-11-05
CA2215166A1 (en) 1996-10-10
IS4569A (is) 1997-09-25
NO974569L (no) 1997-11-21
HRP960156A2 (en) 1997-10-31
PT819113E (pt) 2001-10-30
TNSN96051A1 (fr) 2005-03-15
HK1016964A1 (en) 1999-11-12
EP0819113A1 (en) 1998-01-21
AR002978A1 (es) 1998-05-27
NO974569D0 (no) 1997-10-02
SI0819113T1 (en) 2001-10-31
CZ295852B6 (cs) 2005-11-16
DK0819113T3 (da) 2001-10-15
NZ306204A (en) 1999-01-28
SA96160739B1 (ar) 2005-10-15
DE69613567T2 (de) 2002-04-18
CZ309897A3 (cs) 1998-12-16
IL117629A0 (en) 1996-07-23
MY121206A (en) 2006-01-28
RO116190B1 (ro) 2000-11-30

Similar Documents

Publication Publication Date Title
NO965377L (no) Indolinonforbindelser for behandling av sykdommer
PT966436E (pt) Arilsulfonamidas e analogos e sua aplicacao para o tratamento de doencas neurodegenerativas
NO976063D0 (no) Fremgangsmåte for behandling av diabetes
NO982172D0 (no) Anvendelse av epinastin for behandling av smerter
DE19680452T1 (de) Massagegerät
NO961483L (no) Fremgangsmåte for behandling av oljeholdig formasjon
DK0769017T3 (da) Terapeutiske forbindelser
NO985066D0 (no) Terapeutisk behandling for VEGF-relaterte sykdommer
NO953254D0 (no) Substituerte azolonderivater for behandling av sykdommer forårsaket av helikobakter
DE19681419T1 (de) Behandlungssystem
EE03437B1 (et) Benseenamiidid neurodegeneratiivsete haiguste ravimiseks
NO973081D0 (no) Fremgangmåte for behandling av kroniske progressive vaskulære sykdommer
NO981822L (no) Anvendelse av proteinet GAX for behandling av cancer
NO973366D0 (no) Fremgangsmåte for behandling av multippel sklerose
FI980091A0 (fi) Menetelmä ylijäämäaktiivilietteen käsittelemiseksi
NO982562D0 (no) Sammensetning for behandling av smerte
NO20002481D0 (no) Kombinasjonsterapi for behandling av AIDS
DE59610423D1 (de) Partikulare arzneiform
FI943989A0 (fi) Terapeuttisia tai ehkäiseviä aineita peroksilipidiin liittyviin sairauksiin
KR970020845U (ko) 근골격계질환 치료보조용 테이프
DE29509352U1 (de) Gesundastpflaster
DE29508067U1 (de) Einrichtung zur physiotherapeutischen Behandlung
NO952526D0 (no) Metoder for behandling av reumatisme
FI960790A (fi) Menetelmä fluoreenibisfenolin valmistamiseksi
KR970012147U (ko) 팔찌용 지압구

Legal Events

Date Code Title Description
MM4A Lapsed by not paying the annual fees

Effective date: 20020403